Nomura Toshiyuki, Katunuma Nobuhiko
Takeda Pharmaceutical Company, Ltd., Pharmacology Research Laboratories I, Osaka, Japan.
J Med Invest. 2005 Feb;52(1-2):1-9. doi: 10.2152/jmi.52.1.
Tumor cell invasion and metastasis are associated with the proteolytic activity of various types of proteinases. Among them, cathepsins, which are lysosomal proteinases, have received more attention recently. Since elevated expressions of cathepsins and diminished levels of their inhibitors have been observed in several human cancers, including breast, gastric and prostate cancer, especially in aggressive cancer cells, cathepsins have been suggested to be biological markers of malignant tumors and have proved useful for prognosis of the disease. Furthermore, cathepsins have various roles in cancer progression. Cathepsin D has a mitogenic activity independent of its proteolytic activity and it attenuates the anti-tumor immune response of decaying chemokines to inhibit the function of dendritic cells. Cathepsins B and L have been shown to play an important role in matrix degradation and cell invasion. The administration of their inhibitors prevents the invasion and metastasis of cancer cells. These results indicate that cancer cells orchestrate various cathepsins to progress malignant diseases. Cathepsins may be a potential target for cancer therapy.
肿瘤细胞的侵袭和转移与多种蛋白酶的蛋白水解活性有关。其中,组织蛋白酶作为溶酶体蛋白酶,近年来受到了更多关注。由于在包括乳腺癌、胃癌和前列腺癌在内的几种人类癌症中,尤其是在侵袭性癌细胞中,已观察到组织蛋白酶的表达升高及其抑制剂水平降低,因此组织蛋白酶被认为是恶性肿瘤的生物标志物,并已被证明对疾病的预后有用。此外,组织蛋白酶在癌症进展中具有多种作用。组织蛋白酶D具有独立于其蛋白水解活性的促有丝分裂活性,并且它减弱了趋化因子降解对抑制树突状细胞功能的抗肿瘤免疫反应。组织蛋白酶B和L已被证明在基质降解和细胞侵袭中起重要作用。给予其抑制剂可防止癌细胞的侵袭和转移。这些结果表明,癌细胞通过协调各种组织蛋白酶来推动恶性疾病的发展。组织蛋白酶可能是癌症治疗的潜在靶点。